TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Accolade Stock

Accolade Stock

accolade.comHealthcare / Other HealthcareFounded: 2007Funding to Date: $240.34MM

Accolade is the provider of a personalized health and benefits solution intended to dramatically improves the experience, outcomes and cost of healthcare for employers, health plans and their members.

Buy or sell Accolade stockLearn more about Accolade IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Accolade, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Accolade’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Accolade.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Accolade investors also invested in these private companies

Andreessen Horowitz
Madrona Venture Group

Team

Management Team

Stephen Barnes
Chief Financial Officer
Mike McGee
Chief Information Security Officer
J. Michael Cline
Co-Founder & Board Member
Rajeev Singh
Chief Executive Officer and Board Member
Robert Cavanaugh
President, Field Operations
Harish Naidu
Chief Technology Officer
Shantanu Nundy MD
Chief Medical Officer

Board Members

Dawn Lepore
John Rowe
Peter Klein
Thomas Neff
Spencer Stuart
Edgar Bronfman Jr.
Jeffrey Jordan
Andreessen Horowitz
Mark Mactas
Charles Patton
Rajeev Singh
James Madden
Carrick Capital Partners
J. Michael Cline
Matthew McIlwain
Madrona Venture Group
Michael Yang
Comcast Ventures
William Frist MD
Carrick Capital Partners

Frequently Asked Questions About Accolade’s Stock

plusminus
Can you buy Accolade’s stock?
Accolade is not publicly traded on NYSE or NASDAQ in the U.S. To buy Accolade’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Accolade’s stock?
Yes, you can sell stock of a private company like Accolade. Forge can help you sell your Accolade stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Accolade’s stock price?
Accolade is a privately held company and therefore does not have a public stock price. However, you may access Accolade’s private market stock price with Forge Data.
plusminus
What is Accolade’s stock ticker symbol?
Accolade does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Accolade in the Other Healthcare sector

Phil

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$300.91MM

Insightec

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$500MM

Blink Health

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$1.26B

Selkirk Pharma

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$2.45B

Zephyr AI

Sector
Healthcare / Other Healthcare
 
 

Parallel

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$2.47B

Reven Pharmaceuticals

Sector
Healthcare / Other Healthcare
 
 

Nutrafol

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$150MM

Lumicell

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$315.94MM

News Highlights

Crunchbase 03/03/2020
Accolade Is Latest To Join Health Service IPO Bandwagon
Venture-backed health care service providers follow the IPO trail with successful results.
Pymnts.Com 03/02/2020
Mobile Health Benefit Platform Accolade Seeks IPO | PYMNTS.com
Health tech startup Accolade, with headquarters in Seattle and Philadelphia, filed with the Security and Exchange Commission (SEC). 
GeekWire 11/01/2019
Tech Moves: Accolade names chief medical officer; Apptio hires marketing lead; Rigado has a new CEO
Tech Moves: Accolade names chief medical officer; Apptio hires marketing lead; Rigado has a new CEO

Trending Companies

Frequently Asked Questions

Updated on: Apr 25, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.